United States · FDA National Drug Code directory
CYCLOBENZAPRINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 60760-767_52fc0f77-8c95-1cbd-e063-6394a90a24ad
- Product NDC
- 60760-767
- Form
- TABLET, FILM COATED
- Composition / generic term
- cyclobenzaprine hydrochloride
- Labeler
- ST. MARY'S MEDICAL PARK PHARMACY
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170531
- Source listing expiry
- 20271231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-767-04) · 60760-767-04
- 9 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-767-09) · 60760-767-09
- 15 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-767-15) · 60760-767-15
- 20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-767-20) · 60760-767-20
- 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-767-30) · 60760-767-30
- 60 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-767-60) · 60760-767-60
- 90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (60760-767-90) · 60760-767-90
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →